Document is current
Any future updates will be listed below
-
Authors
Jain, Aakanksha
Gyori, Benjamin M. https://orcid.org/0000-0001-9439-5346
Hakim, Sara
Jain, Ashish
Sun, Liang
Petrova, Veselina https://orcid.org/0000-0002-5593-0198
Bhuiyan, Shamsuddin A.
Zhen, Shannon https://orcid.org/0009-0007-7446-3074
Wang, Qing
Kawaguchi, Riki
Bunga, Samuel
Taub, Daniel G. https://orcid.org/0000-0003-0363-6031
Ruiz-Cantero, M. Carmen
Tong-Li, Candace https://orcid.org/0000-0003-2733-5225
Andrews, Nicholas
Kotoda, Masakazu
Renthal, William
Sorger, Peter K. https://orcid.org/0000-0002-3364-1838
Woolf, Clifford J. https://orcid.org/0000-0002-6636-3897
-
Funding
Funding for this research was provided by:
United States Department of Defense | Defense Advanced Research Projects Agency (HR0011-19-2-0022, W911NF-20-1-0255, HR0011-19-2-0022)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R35NS105076)
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
Jane Coffin Childs Memorial Fund for Medical Research
- License Information
-
More Information
Article History
Received: 5 June 2023
Accepted: 25 April 2024
First Online: 28 May 2024
Competing interests
: C.J.W. is a founder of Nocion Therapeutics, Quralis and Blackbox Bio, an SAB member of Lundbeck, Axonis and Tafalgie Therapeutics, and a consultant for GSK. P.K.S. is a member of the Board of Directors of Glencoe Software and Applied Biomath, a member of the SAB for RareCyte, NanoString and Montai Health, and a consultant for Merck. The remaining authors declare no competing interests.
